论文部分内容阅读
目的观察血塞通加丁咯地尔治疗急性脑梗死的疗效与安全性。方法将92例初发性脑梗死患者随机分为两组,治疗组46例,应用血塞通500mg,加入生理盐水250ml静脉滴注,盐酸丁咯地尔100mg加入生理盐水250ml静脉滴注,1次/d,14d一个疗程。对照组46例,应用川芎嗪注射液80mg加入低分子右旋糖酐500ml静脉滴注,1次/d,14d一个疗程。结果治疗组总有效率91.30%,对照组总有效率67.39%,2组间有统计学差异(P<0.05)。结论血塞通加丁咯地尔治疗急性脑梗死疗效肯定,安全有效。
Objective To observe the efficacy and safety of Xuesaitong plus Buflomedil in the treatment of acute cerebral infarction. Methods 92 patients with primary cerebral infarction were randomly divided into two groups, the treatment group of 46 cases, the use of Xuesaitong 500mg, added 250ml of saline intravenous infusion of buflomedil hydrochloride 100mg normal saline 250ml intravenous infusion of 1 Times / d, 14d a course of treatment. The control group of 46 cases, the application of ligustrazine injection 80mg low molecular dextran 500ml intravenous infusion, 1 / d, 14d a course of treatment. Results The total effective rate was 91.30% in the treatment group and 67.39% in the control group, with statistical significance (P <0.05). Conclusion Xuesaitong plus buflomedil treatment of acute cerebral infarction is effective, safe and effective.